Cargando…
A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of allogeneic and autologous hematopoietic cellular therapy (HCT), associated with significant morbidity and mortality. Although the central drivers of the disease are thought to be endothelial damag...
Autores principales: | Schoettler, Michelle L., Bhatt, Harshil, Vasu, Sumithira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933706/ https://www.ncbi.nlm.nih.gov/pubmed/36818475 http://dx.doi.org/10.3389/fimmu.2022.1064203 |
Ejemplares similares
-
Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy
por: Okamura, Hiroshi, et al.
Publicado: (2021) -
Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis
por: Zhang, Rui, et al.
Publicado: (2021) -
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research
por: Schoettler, M.L., et al.
Publicado: (2023) -
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
por: Schoettler, Michelle, et al.
Publicado: (2022) -
Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy
por: Kaartinen, Kati, et al.
Publicado: (2020)